Biotechnology
Stocks Ranked by
Market Capitalization
| Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|
551
Moleculin Biotech
MBRX
$2.83M
| $2.83M | $0.4000 | 60.8% |
|
552
Artelo Biosciences
ARTL
$2.68M
| $2.68M | $0.7700 | 1.96% |
|
553
Clearmind Medicine
CMND
$2.51M
| $2.51M | $1.69 | 4.32% |
|
|
GRI
554
GRI Bio
GRI
$2.44M
| $2.44M | $1.38 | 2.13% |
|
|
PPCB
555
Propanc Biopharma
PPCB
$2.3M
| $2.3M | $1.01 | 2.88% |
|
|
DCOY
556
Decoy Therapeutics
DCOY
$2.19M
| $2.19M | $4.11 | 4.85% |
|
557
Virax Biolabs
VRAX
$2.09M
| $2.09M | $2.62 | 6.43% |
|
|
SLXN
558
Silexion Therapeutics
SLXN
$2M
| $2M | $1.88 | 2.17% |
|
559
CDT Equity Inc
CDT
$1.85M
| $1.85M | $2.93 | 9.33% |
|
|
BBLG
560
Bone Biologics
BBLG
$1.53M
| $1.53M | $0.8457 | 1.67% |
|
|
SCNI
561
Scinai Immunotherapeutics
SCNI
$1.41M
| $1.41M | $0.2730 | 1.09% |
|
|
PPBT
562
Purple Biotech
PPBT
$1.31M
| $1.31M | $1.40 | 2.19% |
|
|
VBIO
563
Valion Bio
VBIO
$1.29M
| $1.29M | $0.3100 | 11.5% |
|
|
VIVS
564
VivoSim Labs
VIVS
$1.2M
| $1.2M | $0.3446 | 10.7% |
|
|
BDRX
565
Biodexa Pharmaceuticals
BDRX
$1.19M
| $1.19M | $1.32 | 10.8% |
|
566
Lexaria Bioscience
LEXX
$646K
| $646K | $0.3910 | 1.34% |
|
Biotechnology Stocks at a Glance
Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.
There are 566 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.2T.
The largest by market cap are Vertex Pharmaceuticals (VRTX) at $121B, Regeneron Pharmaceuticals (REGN) at $78.5B and argenx (ARGX) at $53.4B.
Among institutional investors, Atrium Therapeutics (RNA) drew the most net new fund positions in Q1 2026: 162 funds opened new positions.
- Combined market cap: $1.2T across 566 stocks.
- Largest constituent: Vertex Pharmaceuticals (VRTX), $121B market cap.
- Most net new fund positions in Q1 2026: Atrium Therapeutics (RNA), +162 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.